Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

4 things to know about the QuintilesIMS drivers of medicine spending in the U.S. report

September 28, 2017

Many patients are struggling to access the medicine they need and have important questions about their medicine costs.

Read More

Profiles in courage: Latinos in the fight against Alzheimer’s

September 28, 2017

President Lyndon B. Johnson established Hispanic Heritage Week in 1968, declaring, “This heritage is ours.”

Read More

PhRMA Announces Support for Seven-Day Script Limit on Opioid Medicines for Acute Pain

September 27, 2017

Pharmaceutical Research and Manufacturers for America CEO Stephen J. Ubl issued a statement.

Read More

Biopharma leads sustained economic growth driven by IP-intensive industries

September 26, 2017

The biopharmaceutical industry is the global leader in generating innovative medicines & technologies, lesser known is the role in sustaining economic growth.

Read More

Johnson & Johnson, Pfizer, Walgreens and other CEOs discuss value in the future of health care

September 21, 2017

As part of The Value Collaborative, we hosted an event with Bloomberg about unlocking and supporting value in the future of health care.

Read More

More than 85 medicines in development for Alzheimer’s disease

September 21, 2017

There are 87 potential new treatments in clinical trials for Alzheimer’s disease.

Read More

The journey to better health care requires a holistic view

September 18, 2017

The journey to better health care requires a holistic view.

Read More

What they are saying: Study on cancer R&D costs is not an accurate representation of marketplace

September 12, 2017

There's more to research and development costs of cancer medicines than this recent study shows.

Read More

PhRMA Statement on Commissioner Scott Gottlieb’s Address to the Regulatory Affairs Professionals Society 2017 Regulatory Conference

September 12, 2017

PhRMA director, Public Affairs, Andrew Powaleny issued a statement following U.S. FDA Commissioner Scott Gottlieb’s address to the Regulatory Affairs Professionals Society 2017 Regulatory Conference.

Read More

Medicare Monday: Medicare Part D by the numbers

September 11, 2017

Key stats about Medicare Part D.

Read More